Skip to content

Clinical trials

Retinal Vein Occlusion trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinal Vein Occlusion Country / region: United States Clear all

103 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20024
20031
20044
20052
20065
20072
20095
20109
20117
20127
20138
20145
20155
20162
20173
20183
20198
20205
20217
20224
20241
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed70
Terminated16
Unknown status8
Recruiting4
Active, not recruiting2
Withdrawn2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergan6
National Eye Institute (NEI)6
Novartis Pharmaceuticals5
Clearside Biomedical, Inc.4
Barnes Retina Institute3
Hoffmann-La Roche3
Johns Hopkins University3
Peter A Campochiaro, MD3
Regeneron Pharmaceuticals3
The Emmes Company, LLC3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinal Vein Occlusion103
Macular Edema46
Macular Degeneration25
Diabetic Retinopathy20
Retinal Diseases8
Vision Disorders7
Wet Macular Degeneration5
Choroidal Neovascularization3
Epiretinal Membrane3
Eye Diseases3

Trials

Showing 51 to 75 of 103. Each trial links to its page on Pharma Observatory.

3 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.